Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Reclast (zoledronic acid) Injection
Company: Novartis Pharmaceuticals Corporation
NDA: 022080
Approval Date: 8/17/2007


Date created: October 3, 2008

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.